Bankrupt Savient Takes $120M Bid From Pharma Co. Crealta

Drug developer Savient Pharmaceuticals Inc. announced Tuesday it will sell the bulk of its assets to Crealta Pharmaceuticals LLC, which submitted a $120.4 million offer at the company's bankruptcy auction. ...read more

  • Tags: